Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT01371201

First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma

The FIRSTMAPPP study is a randomized, double-blind, phase II, international, multicenter study which aims to determine the efficacy of Sunitinib on the progress…

France, Germany +2 more78 participantsStarted 2011-12-22

Treatment: Sunitinib, Placebo